| Date(s) |
Auteur(s) |
Titre de l’article, lien et remarques entre crochets |
| |
|
|
| 13/09/2016 |
Stat |
Ego, ambition, and turmoil: Inside one of biotech’s most secretive startups (Moderna, mRNA, Stéphane Bancel) |
| 11/07/2016 |
Phys Life Rev. |
Mathematical models to characterize early epidemic growth: A Review, Gerardo Chowell et al. |
| 05/2016 |
J. of Virus Eradication |
SARS coronavirus has antibody-dependent enhancement (ADE) effect through the autologous antibodies against envelope spikes on Fcγ receptor expressing cells [SARS-CoV-1] |
| 30/03/2016 |
ACS Infect. Dis. |
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates, Qidi Wang et al. (SARS-CoV, ADE) |
| 16/03/2016 |
PNAS |
SARS-like WIV1-CoV poised for human emergence, Vineet D. Menachery, ... and Ralph S. Baric |
| 09/11/2015 |
Nature medicine |
A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence, Vineet D Menachery, ..., Zhengli-Li Shi & Ralph S Baric |
| 19/09/2014 |
Nature |
mRNA-based therapeutics — developing a new class of drugs, Ugur Sahin, Katalin Karikó & Özlem Türeci |
| 17/03/2014 |
Libération |
Comment les cigarettiers ont roulé le monde entier (Big Tobacco, Golden Holocaust, Robert N. Proctor) |
| 13/03/2014 |
Patents |
Removal of DNA fragments in mRNA production process, Stephane Bancel, Moderna, Patent US10077439B2 [activation of innate response, potential to be oncogenic] |
| 08/01/2013 |
IHU Marseille |
Cours de Didier Raoult (L3) : Les infections au XXIe siècle [Pourquoi pas de vaccin contre les trois "big three" de l'OMS : HIV, tuberculose, paludisme - SARS-CoV n°1 à 0:20:40 - Prédictions de Ferguson - Lavage des mains contre les virus respiratoires et masques - Virus d'hiver - Figatelli, hépatite E et PCR, etc.] |
| 26/04/2012 |
Le Figaro |
La direction d'AstraZeneca débarquée (Louis Schweitzer président) |
| 07/07/2011 |
Expert Opin Drug Metab Toxicol. |
Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy |
| 01/02/2011 |
Sénat |
La gestion d'une crise sanitaire : la pandémie de grippe A (H1N1) |
| 04/11/2010 |
PLOS |
Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture, Aartjan Velthuis, ...Ralph S Baric et al. |
| 11/02/2010 |
Eur Respir J. |
Azithromycin induces anti-viral responses in bronchial epithelial cells, V Gielen et al. |
| 24/05/2009 |
The Times |
Billionaire club in bid to curb overpopulation (Bill Gates, David Rockefeller Jr, Warren Buffett, George Soros) |
| 03/05/2009 |
WHO/OMS |
Advice on the use of masks in the community setting in Influenza A (H1N1) outbreaks |
| 09/02/2009 |
Nature |
The spike protein of SARS-CoV — a target for vaccine and therapeutic development, Lanying Duet al. |
| 01/10/2008 |
Journal of Infectious Diseases |
Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness, Anthony Fauci |
| 10/04/2007 |
PNAS |
Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation, Christian Kannemeier et al. |
| --/--/2006 |
Ralph S. Baric |
Synthetic Viral Genomics: Risks and Benefits for Science and Society, Ralph S. Baric, University of North Carolina at Chapel Hill |
| 01/07/2006 |
Clinical Chemistry |
Preparation of a Chimeric Armored RNA as a Versatile Calibrator for Multiple Virus Assays, Qiuying Huang et al. (SARS-CoV1 and SARS-CoV2) |
| 22/08/2005 |
Virology Journal |
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, Vincent et al. [SARS-CoV n°1 découvert en Chine en 2002] |
| 10/01/2005 |
Nature |
Caution raised over SARS vaccine (Jab against one strain might worsen infection with others) |
| 00/08/2004 |
The Lancet |
SARS, emerging infections, and bioterrorism preparedness, Dr Stephen G Weber et al. |
| 15/01/2004 |
Nature |
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation, Z Wang et al. |
| 00/11/2003 |
The Lancet |
Effects of chloroquine on viral infections: an old drug against today's diseases, Savarino et al. [HIV, SARS, antiviral and immunomodulatory effects] |
| 20/10/2003 |
PNAS |
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus, Boyd Yount, ... and Ralph S. Baric |
| 28/04/2003 |
US patent |
Antiviral agents for the treatment, control and prevention of infections by coronaviruses (US7151163B2, Sequoia Pharmaceuticals Inc) |
| 25/04/2003 |
US patent |
Coronavirus isolated from humans (US7220852B1, CDC) |
| 19/10/1999 |
J. Cell. Physiol. |
Gene therapy using SV40-derived vectors: What does the future hold?, David S. Strayer (simian virus-40) |
